Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Bisubstrate inhibitors of 6-hydroxymethyl-7,8-dihydroptein pyrophosphokinase: Toward cell permeability
  2. Shi,Genbin; Shaw,Gary; Ji,Xinhua
  3. Bioorganic & Medicinal Chemistry Letters. 2024, Sep 25; 129977.
  1. 2.   Antibacterial Gel Coatings Inspired by the Cryptic Function of a Mussel Byssal Peptide
  2. Fichman, Galit; Andrews, Caroline; Patel,Nimit; Schneider,Joel
  3. Advanced materials (Deerfield Beach, Fla.). 2021, Aug 22; e2103677.
  1. 3.   Bisubstrate inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: Transition state analogs for high affinity binding
  2. Shi,Genbin; Shaw,Gary; Zhu, Fengxia; Tarasov,Sergey; Ji,Xinhua
  3. Bioorganic & Medicinal Chemistry. 2021, Jan 1; 29: 115847.
  1. 4.   Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties
  2. Shi, G. B.; Shaw, G.; Liang, Y. H.; Subburaman, P.; Li, Y.; Wu, Y.; Yan, H. G.; Ji, X. H.
  3. Bioorganic & Medicinal Chemistry. 2012, Jan; 20(1): 47-57.
  1. 5.   Unmet challenges of structural genomics
  2. Chruszcz, M.; Domagalski, M.; Osinski, T.; Wlodawer, A.; Minor, W.
  3. Current Opinion in Structural Biology. 2010, Oct; 20(5): 587-597.
  1. 6.   Antifungal activity of recombinant mouse beta-defensin 3
  2. Jiang, Y.; Wang, Y.; Wang, B.; Yang, D.; Yu, K.; Yang, X.; Liu, F.; Jiang, Z.; Li, M.
  3. Letters in Applied Microbiology. 2010, May; 50(5): 468-473.
  1. 7.   Toward understanding the cationicity of defensins - Arg and Lys versus their noncoded analogs
  2. Zou, G. Z.; de Leeuw, E.; Li, C.; Pazgier, M.; Li, C. Q.; Zeng, P. Y.; Lu, W. Y.; Lubkowski, J.; Lu, W. Y.
  3. Journal of Biological Chemistry. 2007, Jul; 282(27): 19653-19665.
  1. 8.   Human defensins: synthesis and structural properties
  2. Pazgier, M.; Li, X.; Lu, W.; Lubkowski, J.
  3. Current Pharmaceutical Design. 2007 13(30): 3096-3118.
  1. 9.   Studies of the biological properties of human beta-defensin 1
  2. Pazgier, M.; Prahl, A.; Hoover, D. M.; Lubkowski, J.
  3. Journal of Biological Chemistry. 2007, Jan; 282(3): 1819-1829.
  1. 10.   Crystal structures of human alpha-defensins HNP4, HD5, and HD6
  2. Szyk, A.; Wu, Z. B.; Tucker, K.; Yang, D.; Lu, W. Y.; Lubkowski, J.
  3. Protein Science. 2006, Dec; 15(12): 2749-2760.
  1. 11.   Expression and purification of recombinant human alpha-defensins in Escherichia coli
  2. Pazgier, M.; Lubkowski, J.
  3. Protein Expression and Purification. 2006, Sep; 49(1): 1-8.
  1. 12.   Effects of select PM-associated metals on alveolar macrophage phosphorylated ERK1 and-2 and iNOS expression during ongoing alteration in iron homeostasis
  2. Prophete, C.; Maciejczyk, P.; Salnikow, K.; Gould, T.; Larson, T.; Koenig, J.; Jaques, P.; Sioutas, C.; Lippmann, M.; Cohen, M.
  3. Journal of Toxicology & Environmental Health-Part A-Current Issues. 2006, MAY 15; 69(10): 935-951.
  1. 13.   Broad spectrum antimicrobial activity of leukocyte extracts from the American alligator (Alligator mississipiensis)
  2. Merchant, M. E.; Leger, N.; Jerkins, E.; Mills, K.; Pallansch, M. B.; Paulman, R. L.; Ptak, R. G.
  3. Veterinary Immunology and Immunopathology. 2006, Apr; 110(3-4): 221-228.
  1. 14.   Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as immune adjuvant
  2. Kurosaka, K.; Chen, Q.; Yarovinsky, F.; Oppenheim, J. J.; Yang, D.
  3. Journal of Immunology. 2005, MAY 15; 174(10): 6257-6265.
  1. 15.   Secondary metabolites of Phlomis viscosa and their biological activities
  2. Calis, I.; Kirmizibekmez, H.; Beutler, J. A.; Donmez, A. A.; Yalcin, F. N.; Kilic, E.; Ozalp, M.; Ruedi, P.; Tasdemir, D.
  3. Turkish Journal of Chemistry. 2005 29(1): 71-81.
  1. 16.   Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction
  2. Walsh, T. J.; Shoham, S.; Petraitiene, R.; Sein, T.; Schaufele, R.; Kelaher, A.; Murray, H.; Mya-San, C.; Bacher, J.; Petraitis, V.
  3. Journal of Clinical Microbiology. 2004, OCT; 42(10): 4744-4748.
  1. 17.   Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense
  2. Yang, D.; Biragyn, A.; Hoover, D. M.; Lubkowski, J.; Oppenheim, J. J.
  3. Annual Review of Immunology. 2004 22: 181-215.
  1. 18.   Roles of antimicrobial peptides such as defensins in innate and adaptive immunity
  2. Oppenheim, J. J.; Biragyn, A.; Kwak, L. W.; Yang, D.
  3. Annals of the Rheumatic Diseases. 2003 62(Suppl. 2): 17-21.
  1. 19.   Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells
  2. Yang, D.; Rosenberg, H. F.; Chen, Q.; Dyer, K. D.; Kurosaka, K.; Oppenheim, J. J.
  3. Blood. 2003 102(9): 3396-3403.
  1. 20.   Antibacterial activity of Barringtonia racemosa
  2. Khan, S.; Jabbar, A.; Hasan, C. M.; Rashid, M. A.
  3. Fitoterapia. 2001 72(2): 162-164.
  1. 21.   Pharmacological evaluation of Bangladeshi medicinal plants - a review
  2. Rahman, S.; Hasnat, A.; Hasan, C. M.; Rashid, M. A.; Ilias, M.
  3. Pharmaceutical Biology. 2001 39(1): 1-6.
  1. 22.   Antibacterial activity of Clausena heptaphylla
  2. Sohrab, M. H.; Mazid, M. A.; Rahman, E.; Hasan, C. M.; Rashid, M. A.
  3. Fitoterapia. 2001 72(5): 547-549.
  1. 23.   The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity
  2. Yang, D.; Chertov, O.; Oppenheim, J. J.
  3. Cellular and Molecular Life Sciences. 2001 58(7): 978-989.
  1. 24.   Biologically active proteins from natural product extracts
  2. O'Keefe, B. R.
  3. Journal of Natural Products. 2001 64(10): 1373-1381.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel